817 related articles for article (PubMed ID: 9610739)
21. Interactions of interleukin-6 promoter polymorphisms with dietary and lifestyle factors and their association with bone mass in men and women from the Framingham Osteoporosis Study.
Ferrari SL; Karasik D; Liu J; Karamohamed S; Herbert AG; Cupples LA; Kiel DP
J Bone Miner Res; 2004 Apr; 19(4):552-9. PubMed ID: 15005841
[TBL] [Abstract][Full Text] [Related]
22. Osteoporosis: new hope for the future.
Masi L; Bilezikian JP
Int J Fertil Womens Med; 1997; 42(4):245-54. PubMed ID: 9309458
[TBL] [Abstract][Full Text] [Related]
23. Bone histomorphometry in the pathophysiological evaluation of primary and secondary osteoporosis and various treatment modalities.
Steiniche T
APMIS Suppl; 1995; 51():1-44. PubMed ID: 7669370
[TBL] [Abstract][Full Text] [Related]
24. Involutional osteoporosis.
Riggs BL; Melton LJ
N Engl J Med; 1986 Jun; 314(26):1676-86. PubMed ID: 3520321
[No Abstract] [Full Text] [Related]
25. [Biochemical markers of bone turnover : clinical usefulness in osteoporosis].
Garnero P; Delmas PD
Ann Biol Clin (Paris); 1999; 57(2):137-48. PubMed ID: 10210740
[TBL] [Abstract][Full Text] [Related]
26. Cancellous bone remodeling in type I (postmenopausal) osteoporosis: quantitative assessment of rates of formation, resorption, and bone loss at tissue and cellular levels.
Eriksen EF; Hodgson SF; Eastell R; Cedel SL; O'Fallon WM; Riggs BL
J Bone Miner Res; 1990 Apr; 5(4):311-9. PubMed ID: 2343771
[TBL] [Abstract][Full Text] [Related]
27. Selective estrogen receptor modulators: A possible new treatment of osteoporosis in males.
Kastelan D; Giljevic Z; Kraljevic I; Korsic M
Med Hypotheses; 2006; 67(5):1052-3. PubMed ID: 16790322
[TBL] [Abstract][Full Text] [Related]
28. Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable estrogen.
Khosla S; Melton LJ; Atkinson EJ; O'Fallon WM; Klee GG; Riggs BL
J Clin Endocrinol Metab; 1998 Jul; 83(7):2266-74. PubMed ID: 9661593
[TBL] [Abstract][Full Text] [Related]
29. [Mechanisms of bone loss in osteoporosis].
Chavassieux P; Meunier PJ
Rev Prat; 1995 May; 45(9):1083-8. PubMed ID: 7792529
[TBL] [Abstract][Full Text] [Related]
30. Role of the vitamin D-endocrine system in the pathophysiology of postmenopausal osteoporosis.
Riggs BL
J Cell Biochem; 2003 Feb; 88(2):209-15. PubMed ID: 12520516
[TBL] [Abstract][Full Text] [Related]
31. Bone mass and bone loss in the elderly: a special case?
Cummings SR
Int J Fertil Menopausal Stud; 1993; 38 Suppl 2():92-7. PubMed ID: 8252112
[TBL] [Abstract][Full Text] [Related]
32. Pathogenesis and management of primary osteoporosis.
Bauwens SF; Drinka PJ; Boh LE
Clin Pharm; 1986 Aug; 5(8):639-59. PubMed ID: 3527528
[TBL] [Abstract][Full Text] [Related]
33. Prevention and treatment of osteoporosis with hormone replacement therapy.
Christiansen C
Int J Fertil Menopausal Stud; 1993; 38 Suppl 1():45-54. PubMed ID: 8499959
[TBL] [Abstract][Full Text] [Related]
34. [Therapeutic concepts in the treatment of postmenopausal osteoporosis].
Leidig-Bruckner G; Ziegler R
Ther Umsch; 1994 Nov; 51(11):737-47. PubMed ID: 7839332
[TBL] [Abstract][Full Text] [Related]
35. [Differential therapy of osteoporosis--an overview based on recent findings regarding the pathogenesis].
Schacht E
Z Rheumatol; 1994; 53(5):274-98. PubMed ID: 7810237
[TBL] [Abstract][Full Text] [Related]
36. Physiologic and pharmacologic effects of estrogen and progestins on bone.
DeCherney A
J Reprod Med; 1993 Dec; 38(12 Suppl):1007-14. PubMed ID: 8120857
[TBL] [Abstract][Full Text] [Related]
37. [Physiopathology behind age-related bone loss. New insight in the mechanisms of cellular and molecular biology].
Kassem MS; Mosekilde L; Eriksen EF
Ugeskr Laeger; 1999 Oct; 161(41):5663-6. PubMed ID: 10565234
[No Abstract] [Full Text] [Related]
38. Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis.
Pacifici R
J Bone Miner Res; 1996 Aug; 11(8):1043-51. PubMed ID: 8854239
[TBL] [Abstract][Full Text] [Related]
39. Urinary hydroxypyridinium crosslinks of collagen as markers of bone resorption and estrogen efficacy in postmenopausal osteoporosis.
Seibel MJ; Cosman F; Shen V; Gordon S; Dempster DW; Ratcliffe A; Lindsay R
J Bone Miner Res; 1993 Jul; 8(7):881-9. PubMed ID: 8352070
[TBL] [Abstract][Full Text] [Related]
40. The unitary model for estrogen deficiency and the pathogenesis of osteoporosis: is a revision needed?
Khosla S; Melton LJ; Riggs BL
J Bone Miner Res; 2011 Mar; 26(3):441-51. PubMed ID: 20928874
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
